The Medical Developments International Ltd (ASX: MVP) share price will be on watch this morning follow a positive announcement relating to its Penthrox product. What is Penthrox? Penthrox, or the green whistle, is a fast onset, non-opioid analgesic. It is indicated for pain relief by self-administration in patients with trauma and those requiring analgesia for surgical procedures. It has been used safely and effectively for over 40 years in Australia with more than 5 million units sold. In recent times the company has been looking at expanding its use, hence today’s announcement. What did Medical Developments International announce? This morning the healthcare company announced that data across 11 abstracts of studies conducted throughout Europe have demonstrated multiple positive results of Penthrox. This includes Penthrox demonstrating superiority over intravenous (IV) morphine, paracetamol, ketoprofen, and NSAIDS within a trauma setting. It also found that Penthrox added to the standard of care […]